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Background: Depression is one of the most common disorders in Psychiatric and Primary Care settings and is
associated with significant disability and economic costs. Low-intensity psychological interventions applied by
Information and Communication Technologies (ICTs) could be an efficacious and cost-effective therapeutic option
for the treatment of depression. The aim of this study is to assess 3 low-intensity psychological interventions
applied by ICTs (healthy lifestyle, positive affect and mindfulness) in Primary Care; significant efficacy for depression
treatment has previously showed in specialized clinical settings by those interventions, but ICTs were not used.
Method: Multicenter controlled randomized clinical trial in 4 parallel groups. Interventions have been designed and
on-line device adaptation has been carried out. Subsequently, the randomized controlled clinical trial will be
conducted. A sample of N = 240 mild and moderate depressed patients will be recruited and assessed in Primary
Care settings. Patients will be randomly assigned to a) healthy lifestyle psychoeducational program + improved
primary care usual treatment (ITAU), b) focused program on positive affect promotion + ITAU c) mindfulness + ITAU
or d) ITAU. The intervention format will be one face to face session and four ICTs on-line modules. Patients will be
diagnosed with MINI psychiatric interview. Main outcome will be PHQ-9 score. They will be also assessed by SF-12
Health Survey, Client Service Receipt Inventory, EuroQoL-5D questionnaire, Positive and Negative Affect Scale, Five
Facet Mindfulness Questionnaire and the Pemberton Happiness Index. Patients will be assessed at baseline, post, 6
and 12 post-treatment months. An intention to treat and per protocol analysis will be performed.
Discussion: Low-intensity psychological interventions applied by Information and Communication Technologies
have been not used before in Spain and could be an efficacious and cost-effective therapeutic option for
depression treatment. The strength of the study is that it is the first multicenter controlled randomized clinical trial
of three low intensity and self-guided interventions applied by ICTs (healthy lifestyle psychoeducational program;
focused program on positive affect promotion and brief intervention based on mindfulness) in Primary Care settings.
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Depression is one of the most common disorders in Psy-
chiatric and Primary Care settings [1] and is associated
with significant physical comorbidity [2,3] disability and
economic costs [4]. According to the World Health
Organization, this disorder will become the second most
important cause of disability in 2020 [5]. Previous stud-
ies reported that in Spanish Primary Care, depression
prevalence is between 13.9 and 29% [1,6] and 60% of pa-
tients with depression are attended in a Primary Care
Center [7]. Although general practitioners refer only 5-
10% of the patients with psychiatric disorders to special-
ized services [8], mental health services are collapsed all
over occidental countries.
There is strong evidence that pharmacotherapy and
psychotherapy could be the first-line treatment for de-
pression [9,10]. Although a combination of both have
been shown the best option [11], pharmacotherapy is
the most common intervention in primary care settings
[12], even though relapse is high following cessation,
and many patients prefer psychological therapies [13]. In
the last decades, there has been a growing interest and
commitment to integrate psychotherapy and other men-
tal health services in Primary Care [14]. However, to
date this type of treatment is not being used proportion-
ate in Primary Care. Different factors as professional’s
training, time needed, costs or work overload, profes-
sional’s attitudes and organization, geographical and lo-
gistic difficulties may contribute to it. An important goal
in Primary Care is that the patient could choose psycho-
logical treatment for different reasons: There are patients
that would prefer psychotherapy rather than pharmaco-
logic treatment [15,16], and there is a need to offer alter-
native treatments to the patients that do not respond or
respond partially to antidepressants and can benefit from
the psychotherapy in terms of costs and relapse preven-
tion [17].
One of the most important difficulties to integrate psy-
chotherapy in Primary Care is lack of time. Many treat-
ment protocols, with empirical support, last one hour
weekly during 12-16 sessions. Lack of time and re-
sources suppose important difficulties to the application
of this type of therapy. For these reasons, brief psycho-
therapy for depression is an efficacious alternative [18].
Because of the efficacy of these interventions [10,19,20]
and the challenge that depression suppose to the health
system, nationals and internationals clinical guides [9,10,21]
have proposed a “stepped care” treatment model in Pri-
mary Care by which large proportion of patients is treated
with significant clinical benefits. This therapy is easier and
simpler than formal psychotherapy and it can be used
with nontraditional methods such as internet or mobile
phones. In depressive patients, low-intensity interventions
are recommended to mild and moderate depressivepatients. The main interventions are: Cognitive behavior
therapy (CBT), Computerized Cognitive Behavior Therapy
(CCBT), Self-help programs, Psychoeducational Interven-
tions and mindfulness-based cognitive therapy (MBCT).
Previous research suggests that not all depressed pri-
mary care patients are receiving adequate treatment for
depression [22] therefore, there is an urgent need to
change the way to deliver psychological interventions.
There are recommendations regarding going beyond face-
to-face psychotherapy in order to improve the accessibility
to psychological interventions [23]. In this sense, in the
last years, low-intensity psychological interventions ap-
plied by Information and Communication Technologies
(ICTs) have been shown as an efficacious therapeutic op-
tion for the treatment of many mental health problems,
including depression. In fact, different meta-analysis have
demonstrated that Internet-delivered psychotherapy (iPT)
is effective in the treatment of depression [20,24].
Due to the interest about on-line psychotherapy and
the need to cover therapeutic management of depressive
patients, different European research groups have de-
signed computerized programs for depression preven-
tion and treatment.
Proudfoot and colleagues [25] developed a computer-
ized cognitive behavioral therapy to mild and moderate
depression named “Beating the Blues”. It is the most
used program and the only computerized treatment pro-
gram recommended by NICE for the treatment of people
with this type of disorder at the moment. Another inter-
active program based on CCBT is the MoodGym program
[26] from the Australian National University, developed to
depression prevention [27]. In Spain, there is only one
computerized program based on CCBT to depression
management in primary care setting [28]. At the present,
the study is being conducted by our research group and
results will be presented soon.
Considering that low-intensity psychological interven-
tions applied by Information and Communication Tech-
nologies (ICTs) could be an efficacious and cost-effective
therapeutic option for the treatment of depression, the
aim of the present study will be to assess three low-
intensity psychological interventions (healthy lifestyle
psychoeducational program, focused program on posi-
tive affect promotion and brief intervention based on
mindfulness) applied by ICTs in Primary Care.
Methods
Study design
This is a multicenter controlled randomized clinical trial
in four parallel groups: a) healthy lifestyle psychoeduca-
tional program, b) focused program on positive affect
promotion, c) brief intervention based on mindfulness
and d) improved treatment as usual (ITAU) group in
primary care.
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The recruitment strategy will be performed by General
Practitioners (GPs) from primary health centers of the
four Spanish regions involved in the study (Andalucía,
Aragon, Islas Baleares and Comunidad Valenciana). In-
clusion criteria are: older than 18 years, DSM-5 diagnose
of Major Depression or Dysthymia, mild or moderate
depression expressed as score lower than 14 in the Pa-
tient Health Questionnaire (PHQ) [29], depressive symp-
toms presented for at least two months, be able to read
and understand Spanish language and enough capacity
for understanding and signing the written informed con-
sent form. Exclusion criteria includes any diagnose of
disease that may affect central nervous system (brain
pathology, traumatic brain injury, dementia, etc.), any
psychiatric disorder other than Major Depression, Dys-
thymia, anxiety disorders or personality disorders, any
medical, infectious or degenerative disease that may
affect mood, presence of delusional ideas or hallucina-
tions consistent or not with mood, and suicide risk.
Sample size
According to the literature, with a standard deviation (SD)
of 9.2 and a mean of 16.2 in the control group (ITAU)
[30], 14.59 in the positive affect group [31], 16.12 in the
healthy lifestyle group [32] and 10.3 in the mindfulness
group [30], accepting an alpha of 0.05 and a beta risk < 0.2
in a bilateral contrast, and assuming a 25% patient loss to
follow-up, we need 60 subjects in each condition. There-
fore, the total sample size was determined at 240. This
sample size also allows calculating clinically significant dif-
ference in the main outcome variable, PHQ-9 [29], and
this difference has been placed at 5 points.
Recruitment
The recruitment strategy will be performed in primary
care settings by participating GPs among patients fulfill-
ing study criteria. When the GP identifies a potential
participant, he/she will explain the patient the character-
istics of the study. Whether the patient is interested in
participating he/she will sign an informed consent and
the GP will fill a referral form describing the sociodemo-
graphic characteristics of the patient and a checklist for
inclusion/exclusion criteria, and will give him/her the
patient’s information sheet and a handout describing the
study. If the patient does not want to participate or does
not meet inclusion criteria, the GP will fill the referral
form describing the reason for not including him/her.
The GP will send these documents by fax to the local re-
searcher. Subjects will be interviewed in the next 3 days
by the researcher. After confirming that they have signed
the informed consent and have understood the study
and the treatment options, the researcher will administer
the psychological assessment instruments related withinclusion criteria: MINI International Neuropsychiatric
Interview [33], PHQ-9 [29] and sociodemographic vari-
ables. The researcher will collect baseline data and will
contact an independent researcher to implement the
randomization.
Randomization, allocation and masking of study groups
Each patient will be allocated to either one of the four
groups using a computer-generated random number se-
quence. We will use block allocation, with 4 blocks (one
for each participating region) including 60 patients per
block, with about 60 patients per arm. The allocation
will be carried out by an independent researcher, belong-
ing to REDIAPP (Research Network on Preventative Ac-
tivities and Health Promotion), who is not involved in
the study. The method used to implement the random
allocation sequence will be a central telephone. The se-
quence will be concealed until interventions are assigned.
Patients will agree to participate before the random alloca-
tion and without knowing which treatment they will be al-
located to. Study personnel conducting psychological
assessments will be masked to participants’ treatment
conditions.
The researcher that administers baseline assessments
will be unaware of the treatment group to which the pa-
tient belongs to. This researcher will be different from the
one that administer the questionnaires over the study.
GPs will be also unaware, as long as possible, of the arm
to which the patient has been randomized, since their
treatment should be exclusively based on the recommen-
dations of the guides for the treatment of depression. The
flowchart of the study is summarized in Figure 1.
Interventions
All interventions (except ITAU) are composed of one
face-to-face group session and 4 online, individual and
interactive therapeutic modules.
Face-to-face session will involve 3-5 patients and will
be 90 minutes in length. The aim of this session will be
to explain the program structure and main components
of treatment, and to motivate participants for change.
The online therapeutic modules are oriented to work
on different psychological techniques and the duration
of each module will be approximately 60 minutes. All
modules include an explanation of the module contents,
check questions to test if they understand the contents
and exercises to practice such techniques. These mod-
ules are sequential, in order to move step by step, all
along the program. However, user can review the mod-
ule contents once they are finished. Duration of the pro-
gram can vary among users, it is estimated the duration
for most people will be 4-8 weeks. The participants will
receive two weekly-automated mobile phone messages,
encouraging them to proceed with the program and
Figure 1 Flowchart of the study: Randomization, sampling and monitoring of patients.
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each module. Furthermore, the participants will receive
an automated e-mail encouraging them to continue with
the modules if they have not accessed the program for a
week. The program also offers continued feedback to
users through the assessment tools showing them their
progress throughout the entire treatment process.
All groups of patients will receive treatment as usual
improved by their GPs, as described below in this sec-
tion. All groups of patients will also receive a participant
manual with information about technical aspects of the
online program.
Psychoeducational program for the promotion of a healthy
lifestyle
This program provides information to understand the
relationship between physical and mental health and
physical activity, diet and sleep control.The content of the program is the following:
M1. Beginning of a lifestyle change: This module aims
to teach the importance of healthy lifestyle to improve
emotional health and general well-being and to give
structured hygienic-dietary recommendations. The
patient will learn to identify both healthy and risk
behaviors, and to recognize the most common obstacles
that prevent the depressed patients from adopting a
healthy lifestyle.
M2. Physical activity. Learning to move on: This
module focuses on behavior activation by teaching the
importance of “moving on” and taking regular exercise
to improve mood. In this module the main aim is to give
information about the most recommended exercises to
improve mood, and to train the patient in learning
procedures to increase the motivation, to start being
more active, and to maintain this physical regularly.
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teach the importance of diet to achieve a good
physical and mental health, and the role of the
Mediterranean diet in the prevention and treatment of
depression. For this purpose the obstacles to maintain
a healthy diet will be analyzed.
M4. Sleep. The importance of good sleep: This
module provides information to understand the
relationship between sleep and general health. The
patient will be trained to develop strategies to improve
sleep.
Psychological intervention for the promotion of positive
affect
The purpose of this program is to decrease depressive
symptomatology and to prevent relapses using the pro-
motion of wellbeing and positive affect.
The content of the program is the following:
M1. Learning to live: The first module is dedicated to
the importance of establishing and maintaining an
adequate activity level and the relevance of choosing
activities which are significant, with a personal
meaning for the individual. The content will cover also
the importance of social support in order to make
easier the task of establishing meaningful activities.
The patient will be trained to carry out and monitor
meaningful activities using a therapeutic tool, the
activity diary.
M2. Learning to enjoy: In this module the main aim
is to give education about the effect of positive
emotions and to train the patient in learning
procedures to increase the likelihood of experiencing
positive emotions, promoting the occurrence of
pleasant activities in order to learn to enjoy the
present moment.
M3. Accepting to live: In the previous module the
focus was in positive emotions related with the present
time. In this module the patient will be trained in
focusing in positive emotions related with the past
(like gratitude) or the future (like optimism). This
module also deals with the identification and
management of beliefs and behaviors that disturb the
good moments.
M4. Living and learning: The aim of this module is
to train the patient in understanding life as a
continuous process of learning and personal growth,
emphasizing the training in strategies to promote
psychological strengths, resilience and meaningful
goals linked to important values. The content of the
module will also include understanding the effort
needed in order to achieve a meaningful life, helping
the patient to make a plan for the future to achieve
his/her life goals.Brief intervention based on mindfulness
This program, which aim is to decrease depressive symp-
tomatology using mindfulness, emphasizing the benefits
of this therapy.
The content of the program is the following:
M1. Getting to know mindfulness: This module aims
to show what mindfulness is, prejudices about it, the
inattention problem and some of its main benefits and
recommendations to practice it. Finally, a mindful
practice (the raisin exercise) will be shown.
M2. Establishing formal and informal practices: In
this module it will be raised the importance of the
establishment not only of formal but also of informal
practice. For this purpose different techniques such as
the three minutes practice will be shown.
M3. Thought management, body scan practice and
values: This module aims to help people to see the
importance of values to keep a regular mindfulness
practice. It also will include the body scan practice.
M4. Self-compassion. Integrating mindfulness in
everyday life: This module will help people to establish
a regular practice of mindfulness to be indefinitely kept.
It also will include a very powerful practice, self-
compassion, which has shown efficacy by itself [27].Improved treatment as usual (ITAU)
All the patients included in the study (whatever the treat-
ment group randomly assigned) will be also treated by
their GPs. The Treatment as Usual in primary care will be
improved because the participating GP will receive a train-
ing program on a widely used Spanish Guide for the
Treatment of Depression in Primary Care [7]. In case of
suicide risk, severe social dysfunction or worsening of
symptoms, it is recommended to refer the patient to men-
tal health facilities. In practice, ITAU in primary care is
any kind of treatment administered by the GP to the pa-
tient with depression.Instruments
Patients will be assessed at baseline, post-treatment, and 6
and 12 post-treatment months. The study variables
assessed are summarized in Table 1.Main outcome
The primary outcome will be depressive symptom sever-
ity assessed via PHQ-9 [34] using the Spanish validated
version [29]. This is an instrument for diagnosis and
measuring the severity of depression. PHQ-9 is brief and
it is completed by the patient. It will be registered at four
times: baseline, post-treatment, 6 month follow-up, and
12 month follow-up.
Table 1 Study variables
Instrument Assessment area Time of assessment Applied by
MINI Neuropsychiatric
interview
Psychiatric diagnosis Baseline Researcher A
PHQ-9 Severity of depression Baseline and follow-up sessions* Researcher A (baseline) Online
(follow-up sessions)
Sociodemographic data Gender, age, marital status, education,
occupation, economical level
Baseline Researcher A
SF-12 Health Survey Health-related quality of life Baseline and follow-up sessions* Online
CRSI Health and social services use Baseline and 6 and 12 post-treatment months Researcher A (baseline) Researcher B
(6 and 12 post-treatment months)
EQ-5D Health related quality of life Baseline and 6 and 12 post-treatment months Online
PANAS Positive and negative affect Baseline and 6 and 12 post-treatment months Online
FFMQ Facets and factors of mindfulness Baseline and 6 and 12 post-treatment months Online
PHI Remembered and experienced
well-being
Baseline and 6 and 12 post-treatment months Online
*Follow-up sessions: Post-treatment, 6 and 12 post-treatment months.
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Sociodemographic variables. Relevant sociodemographic
information regarding gender, age, marital status (single,
married/relationship, separated/divorced, and widowed),
education (years of education), occupation, economical
level will be collected.
Mini-International Neuropsychiatric Interview (MINI).
This is a short structured diagnostic psychiatric interview
that yields key DSM-IV and ICD-10 diagnoses [35]. MINI
can be administered in a short period of time and clinical
interviewers need only a brief training. It will be registered
at baseline using its Spanish validated version [33].
SF-12 Health Survey [36]. This instrument consists of
12 items that measure the health-related quality of life. A
psychometric analysis suggested that it has adequate psy-
chometric properties and a validated Spanish version [37].
Client Service Receipt Inventory [38] (CSRI-Spanish
version) [39]. Questionnaire for collecting information
about use of healthcare and social care services and
other economic impacts (such as time off work due to
illness). The variant used in this study was designed to
collect retrospective data on service utilization during
the previous months after the last assessment. Data on
baseline assess the previous six months before inclusion.
EuroQoL-5D questionnaire (EQ-5D – Spanish version)
[40]. Generic instrument of health related quality of life.
It has two parts: Part 1 records self-reported problems
in each of five domains: mobility, self-care, usual activities,
pain/discomfort and anxiety/depression. Each domain is
divided into three levels of severity corresponding to no
problems, some problems and extreme problems, which
allows obtaining a population-based preference score or
societal index (SI). A total of 243 theoretically possible
health states can be obtained and the SI is calculated on
the basis of these health states. Values range from 1 (best
health state) to 0 (death). However, this index may alsoprovide negative values that correspond to health states
perceived as worse than death-. Utility scores for these
health states were assigned using the readily available
Spanish population tariffs [41]. Part 2 records the subject’s
self-assessed health on a VAS, a 10 cm vertical line on
which the best and worst imaginable health states score
100 and 0 respectively.
Positive and Negative Affect Scale (PANAS) [42] PANAS
consists of 20 items that evaluate two independent dimen-
sions: positive affect (PA) and negative effect (NA). The
range for each scale [10 items on each] is 10 to 50. The in-
strument’s psychometric properties are quite satisfactory.
It has a validated Spanish version [43].
Five Facet Mindfulness Questionnaire (FFMQ) [44]:
This questionnaire comprises 39 items that assess five
facets or factors of mindfulness: observing (8 items), de-
scribing (8 items), and acting with awareness (8 items),
not judging inner experience (8 items) and not reacting
to inner experience (7 items). Items are rated using a
Likert scale that ranges from 1 (“never or very rarely
true”) to 5 (“very often or always true”). The Spanish
version of this scale has been validated [45] and has been
shown to have good internal consistency and reliability.
The Pemberton Happiness Index (PHI) [46]. This in-
strument consists of eleven items related to different
domains of remembered well-being (general, hedonic,
eudaimonic and social well-being) and ten items related to
experienced well-being (positive and negative emotional
events that possibly happened the day before). A psycho-
metric analysis suggested that it has adequate psychomet-
ric properties and a validated Spanish version [46].
Ethical aspects
A general overview of the aims and characteristics of the
study and the interventions will be provided to the pa-
tients. They will also be informed that they will be
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withdraw at any time with the guarantee that they will
continue to receive the treatment considered most ap-
propriate by their GP. Informed consent will be obtained
from the participants before they are aware of which
group they are to be included in. For ethical reasons, pa-
tients allocated to Treatment as Usual will be offered the
possibility to complete the psychotherapy program. The
study follows national and international norms (Helsinki
Convention and the Declaration of Madrid of the World
Psychiatric Association). The Study Protocol was ap-
proved by the Comité d’Ètica de la Investigació de les
Illes Balears (CEI-IB) (ref: IB 2144/13 PI).
An important issue in a study using ICTs is participants’
data protection. In order to protect personal information,
AES (Advanced Encryption Standard) strategies regarding
the use of personal passwords and data encryption will be
followed.
Analysis strategy
Analysis of clinical efficacy
Intention-to-treat and per-protocol analysis will be used.
Analysis will include the description and “head-to head”
comparison between the four groups. Descriptive statis-
tics of the included variables (mean and 95 per cent con-
fidence interval for normally distributed quantitative
variables; and median and interquartile range for abnor-
mally distributed quantitative variables) will be performed.
To confirm main hypothesis, all variables will be com-
pared (t0-tk) using an analysis of variance (ANOVA) and
post-hoc tests or Kruskal-Wallis non-parametric tests. Fi-
nally, more sophisticated multivariate analysis, including
multilevel regression, will be used. The effect size of im-
provement and intention-to-treat (ITT) will be estimated.
Descriptions of costing procedure
Data collection on the use and utilization of health and
social services will be collected through the question-
naire Client Service Receipt Inventory (CSRI) Spanish
version [40]. The variant to be used in this study was de-
signed to retrospectively collect data on service use dur-
ing the previous 6 months.
Costs were estimated from the healthcare and societal
perspectives during the six months of follow-up. Direct
health care costs were calculated by adding the costs de-
rived from medication consumption, medical tests, use
of health-related services, and cost of the staff running
the CBT intervention.
The cost of medication will be calculated by determin-
ing the price per milligram according to the Databases
of the drug from the Ministry of Health and Consumer
and included the value-added tax. The total costs of
medications were calculated by multiplying the price per
milligram by the daily dosage used (in milligrams) andthe number of days that the treatment was received. The
main source of the unit cost data for medical tests and
health services will be use the OBLIKUE database of
health care costs. The OBLIKUE database contains in-
formation about Spanish healthcare service costs and
was derived by systematic reviews of the literature; it
consists of approximately 18,000 entries.
Indirect costs (lost productivity): Lost productivity will
be calculated using the human capital approach, which
involves multiplying the minimum daily wage in Spain
for 2014 by the number of days of sick leave, as reported
by each patient. Finally, total costs were calculated by
adding the direct and indirect costs. Unit costs are
expressed in Euros (€) based on 2014 prices.
In our study the general guidelines for conducting
pharmacoeconomic analyzes in Spain and the Inter-
national Society for Pharmacoeconomics and Outcomes
Research (ISPOR) [47,48] will be followed.
Utility scores
Utility scores will be obtained from the questionnaires
quality of life related to health EuroQol 5D and SF-12.
The EQ-5D is used to rate patients’ quality of life on a
scale from 0 (as bad as death) to 1 (perfect health). Nega-
tive values are possible and indicate a health state that is
“worse than death.” QALYs were calculated on the basis of
these scores using the Spanish tariffs of EQ-5D [49].
Along with EQ-5D utility scores, scores recorded on the
EQ VAS were also used as an outcome for the analysis.
Analysis perspective and time horizon The perspec-
tive used in our analysis will be twofold: on one hand
the social perspective, to include all costs and quality of
life and moreover the perspective of the national health
system.
The time horizon of the study is 12 months, so there
will have to use any kind of discount or costs or profits.
Cost-utility analysis
Cost-utility will be explored through the calculation of in-
cremental cost-effectiveness ratios (ICER), defined as the
ratio between incremental costs and incremental effects
measured on QALYs or EQ VAS [50]. QALYs were ap-
proximated by using the area under-the-curve technique.
To estimate the incremental cost effectiveness ratio -
ICER (marginal incremental cost and incremental ef-
fects) the following equation is used:
ICER ¼ Cost strategy 1−Cost strategy 2
effectiveness strategy 1− effectiveness strategy 2
Cost-effectiveness acceptability curves (CEACs) will
also be plotted when necessary [50]. CEACs display the
probability that the intervention is cost-effective, given a
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QALY gained. The curves obtained incorporate the un-
certainty that exists around the estimates of incremental
costs and incremental effects associated with the inter-
vention [51].
Data collection will be performed using EXCEL soft-
ware and then for statistical analysis we used the SPSS
(SPSS Inc., Chicago, IL, USA) software version 20, li-
censed for University of Malaga.
Frequency and proportions used for descriptive statis-
tics of categorical or qualitative variables. For quantita-
tive variables the mean and standard deviation were
obtained.
For inferential statistical test Chi-square test for quali-
tative variables for qualitative and quantitative variables
was used test one-way ANOVA, and for the test of the
T-Student quantitative variables. In all cases statistical
significance corresponded to a value of p <0.05.
Forecast execution dates
Initial recruitment of patients: February 2015
Finalization of patient recruitment: July 2015
Finalization of patient monitoring period: July 2016
Publication of results: December 2016
Discussion
Brief psychotherapy is an effective alternative for depres-
sion treatment to offer in primary care [18]. Moreover,
the effectiveness of Internet-delivered psychotherapy for
this disorder has also been demonstrated [24]. Low-
intensity psychological interventions applied by Informa-
tion and Communication Technologies (ICTs) are not
frequently used in Spain and could be an efficacious and
cost-effective therapeutic option for the treatment of de-
pression. The strength of the study is that, to our know-
ledge, this is the first multicenter controlled randomized
clinical trial of four low intensity and self-guided interven-
tions applied by ICTs (healthy lifestyle psychoeducational
program; focused program on positive affect promotion;
brief intervention based on mindfulness; and improved
treatment as usual group) in Primary Care settings.
Two important limitations of the study will be the
negative attitudes from GP to recommend this treatment
and dropout rates in treatment groups (significantly
greater than in the control group according to previous
studies). Efforts to maintain dropout rates in the range
of 30% and training sessions for participating GPs will
be carried out to overcome these limitations.
Clinical implications
This is probably the first study in Spain aiming to improve
symptomatology and quality of life of depressed patients
using low intensity interventions applied by ICTs. The
treatment programs used in this study includes therapeuticstrategies (mindfulness, healthy lifestyle and positive affect)
that have proven their efficacy for depression treatment,
nerveless it is the first study that adapts these interven-
tions to ICTs.
Efficiency and efficacy of these interventions could be
suitable for implementation from an economic point of
view. Moreover, they could be used in problems were
depression or adjustment disorders are comorbid or
other emotional disorders are presented. In conclusion,
positive results of this study could have a significant im-
pact on the society.
Abbreviations
ICTs: Information and communication technologies; ITAU: Improved primary
care usual treatment; CBT: Cognitive behavior therapy; CCBT: Computerized
cognitive behavior therapy; MBCT: Mindfulness-based cognitive therapy;
iPT: Internet-delivered psychotherapy; GP: General practitioners; PHQ: Patient
health questionnaire; REDIAPP: Research Network on Preventative Activities
and Health Promotion; MINI: Mini-International Neuropsychiatric Interview;
CSRI: Client service receipt inventory; PANAS: Positive and negative affect
scale; FFMQ: Five facet mindfulness questionnaire; PHI: The Pemberton
happiness index; ISPOR: International Society for Pharmacoeconomics and
Outcomes Research; ICER: Incremental cost-effectiveness ratios.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
All the authors participated in developed the original idea for the study and
in the design and planning of the intervention that is evaluated here. In
addition, all authors have read and corrected draft versions, and approved
the final version.
Authors’ information
Adoración Castro, Javier García-Campayo, Mari-Cruz Pérez Yus, Margalida
Vives, Miquel Roca and Margalida Gili REDIAPP “Research Network on
Preventative Activities and Health Promotion” (RD12/0005/0003).
Acknowledgements
The study will be funded by a grand from the Carlos III Health Institute of
the Spanish Ministry Economy and Competitiveness (ETES n° PI13/0117;
PSI2010-17563), co-financed with European Union ERDF funds. We thank
“Red de Investigación en Actividades de Prevención y Promoción de la
Salud” (Research Network on Preventative Activities and Health Promotion)
(RD12/0005/0003), and “CIBER Fisiopatología de la Obesidad y Nutrición” for
its support in the development of this study.
Author details
1Institut Universitari d′Investigació en Ciències de la Salut (IUNICS), University
of Balearic Islands, Palma de Mallorca, Spain. 2Red de Investigación en
Actividades Preventivas y Promoción de la Salud, Instituto de Salud Carlos III,
Madrid, Spain. 3Department of Clinical and Basic Psychology and
Biopsychology, Faculty of Health Sciences, University Jaume I, Castellon,
Spain. 4Department of Psychiatry. Hospital Miguel Servet, University of
Zaragoza, Zaragoza, Spain. 5Mental Health Department, University Regional
Hospital of Málaga, Institute of Biomedicine of Málaga, Málaga, Spain.
6Department of Psychological, Personality, Evaluation and Treatment,
University of Valencia, Valencia, Spain. 7CIBER Fisiopatología Obesidad y
Nutrición (CIBERobn), Instituto Salud Carlos III, Madrid, Spain.
Received: 19 March 2015 Accepted: 23 April 2015
References
1. Roca M, Gili M, Garcia-Garcia M, Salva J, Vives M, Garcia Campayo J, et al.
Prevalence and comorbidity of common mental disorders in primary care.
J Affect Disord. 2009;119(1-3):52–8.
Castro et al. BMC Psychiatry  (2015) 15:106 Page 9 of 102. Gili M, Garcia-Toro M, Vives M, Armengol S, Garcia-Campayo J, Soriano JB,
et al. Medical comorbidity in recurrent versus first-episode depressive
patients. Acta Psychiatr Scand. 2011;123(3):220–7.
3. Roca-Bennasar M, Gili-Planas M, Ferrer-Pérez V, Bernardo-Arroyo M. Mental
disorders and medical conditions. J Psychosom Res. 2001;50(1):39–44.
4. Fernández A, Saameño JAB, Pinto-Meza A, Luciano JV, Autonell J, Palao D,
et al. Burden of chronic physical conditions and mental disorders in primary
care. Br J Psychiatry. 2010;196(4):302–9.
5. World Health Organization. The global burden of disease. Geneve: WHO; 2001.
6. Alonso J, Angermeyer MC, Bernert S, Bruffaerts R, Brugha TS, Bryson H, et al.
Use of mental health services in Europe: results from the European study of
the Epidemiology of Mental Disorders (ESEMeD) project. Acta Psychiatr
Scand Suppl. 2004;420:47–54.
7. Fernández A, Haro JM, Codony M, Vilagut G, Martínez-Alonso M, Autonell J,
et al. Treatment adequacy of anxiety and depressive disorders: primary
versus specialised care in Spain. J Affect Disord. 2006;96(1-2):9–20.
8. Agüera LF, Reneses B, Muñoz P. Enfermedad mental en atención primaria.
Madrid: Flas; 1996.
9. García-Herrera JM, Nogueras-Morillas V, Muñoz-Cobos F, Morales-Asensio
JM. Guía de Práctica Clínica para el tratamiento de la depresión en Atención
Primaria [Clinical Practice Guide on the Treatment of Depression in Primary
Care]. Distrito Sanitario Málaga UGC Salud Mental Hospital Regional
Universitario “Carlos Haya”. Málaga: GAEDAP; 2011.
10. National Collaborating Centre for Mental Health. Depression in Adults: The
treatment and management of depression in adults. 2009. http://www.nice.
org.uk/guidance/cg90/resources/guidance-depression-in-adults-pdf.
Accessed October 2015.
11. Cuijpers P. Combined pharmacotherapy and psychotherapy in the
treatment of mild to moderate major depression? JAMA psychiatry.
2014;71(7):747–8.
12. Gill D, Hatcher S. WITHDRAWN: antidepressants for depression in medical
illness. Cochrane Database Syst Rev. 2000;18(4), CD001312.
13. Van Schaik DJF, Klijn AFJ, van Hout HPJ, van Marwijk HWJ, Beekman ATF, de
Haan M, et al. Patients’ preferences in the treatment of depressive disorder
in primary care. Gen Hosp Psychiatry. 2004;26(3):184–9.
14. DeLeon PH, Rossmando NPSB. The future is primary care. In: Frank RG,
McDaniel SH, Bray JHM, editors. Primary care psychology. Washington: APA;
2004. p. 63–92.
15. Backenstrass M, Joest K, Frank A, Hingmann S, Mundt C, Kronmüller KT.
Preferences for treatment in primary care: a comparison of nondepressive,
subsyndromal and major depressive patients. Gen Hosp Psychiatry.
2006;28(2):178–80.
16. McHugh RK, Whitton SW, Peckham AD, Welge JA, Otto MW. Patient
preference for psychological vs pharmacologic treatment of psychiatric
disorders. J Clin Psychiatry. 2013;74(06):595–602.
17. Hollon SD. Does cognitive therapy have an enduring effect? Cogn Ther Res.
2003;27(1):71–5.
18. Rimer J, Dwan K, Lawlor DA, Greig CA, McMurdo M, Morley W, et al.
Exercise for depression. Cochrane Database Syst Rev. 2012;7, CD004366.
19. National Collaborating Centre for Mental Health: Computerised cognitive
behaviour therapy for depression and anxiety: Review of Technology
Appraisal 51. 2006. http://www.nice.org.uk/guidance/ta97/resources/
guidance-computerised-cognitive-behaviour-therapy-for-depression-and-
anxiety-pdf. Accessed October 2014.
20. Andersson G, Cuijpers P. Internet-based and other computerized
psychological treatments for adult depression: a meta-analysis. Cogn Behav
Ther. 2009;38(4):196–205.
21. Nieuwsma JA, Trivedi RB, Mcduffie J, Kronish I, Benjamin D, Williams JW.
Brief psychotherapy for depression: a systematic review and meta-analysis.
Int J Psychiatry Med. 2012;43(2):129–51.
22. Uebelacker LA, Smith M, Lewis AW, Sasaki R, Miller IW. Treatment of
depression in a low-income primary care setting with colocated mental
health care. Fam Syst Health. 2009;27(2):161–71.
23. Kazdin AE, Blase SL. Rebooting psychotherapy research and practice to
reduce the burden of mental illness. Perspect Psychol Sci. 2011;6(1):21–37.
24. Burns MN, Begale M, Duffecy J, Gergle D, Karr CJ, Giangrande E, et al.
Harnessing context sensing to develop a mobile intervention for
depression. J Med Internet Res. 2011;13(3):e55.
25. Proudfoot J, Goldberg D, Mann A, Everitt B, Marks I, Gray JA. Computerized,
interactive, multimedia cognitive-behavioural program for anxiety and
depression in general practice. Psychol Med. 2003;33(2):217–27.26. Australian National University: MoodGYM: https://moodgym.anu.edu.au/
welcome. Accessed October 2014.
27. Christensen H, Griffiths KM, Jorm AF. Delivering interventions for depression
by using the internet: randomised controlled trial. Br Med J.
2004;328(7434):265–8.
28. López-del-Hoyo Y, Olivan B, Luciano JV, Mayoral F, Roca M, Gili M, et al. Low
intensity vs. self-guided internet-delivered psychotherapy for major
depression: a multicenter, controlled, randomized study. BMC Psychiatry.
2013;13:21.
29. Diez-Quevedo C, Rangil T, Sanchez-Planell L, Kroenke K, Spitzer RL.
Validation and utility of the patient health questionnaire in diagnosing
mental disorders in 1003 general hospital Spanish inpatients. Psychosom
Med. 2001;63(4):679–86.
30. Van Aalderen JR, Donders ART, Giommi F, Spinhoven P, Barendregt
HP, Speckens AEM. The efficacy of mindfulness-based cognitive
therapy in recurrent depressed patients with and without a current
depressive episode: a randomized controlled trial. Psychol Med.
2012;42(5):989–1001.
31. Titov N, Andrews G, Davies M, McIntyre K, Robinson E, Solley K. Internet
treatment for depression: a randomized controlled trial comparing clinician
vs. technician assistance. PLoS One. 2010;5(6):e10939.
32. Chalder M, Wiles NJ, Campbell J, Hollinghurst SP, Haase AM, Taylor AH, et al.
Facilitated physical activity as a treatment for depressed adults: randomised
controlled trial. BMJ. 2012;344:e2758.
33. Ferrando L, Franco L, Soto M, Bobes J, Soto O, Gibert J. MINI: Mini
International Neuropsychiatric Interview. Versión en Español 5.0.0. Madrid:
IAP; 1998.
34. Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression
severity measure. J Gen Intern Med. 2001;16(9):606–13.
35. Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, et al.
The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development
and validation of a structured diagnostic psychiatric interview for DSM-IV
and ICD-10. J Clin Psychiatry. 1998;59 Suppl 2:22–33.
36. Ware J, Kosinski M, Keller SD. A 12-item short-form health survey:
construction of scales and preliminary tests of reliability and validity. Med
Care. 1996;34(3):220–33.
37. Gandek B, Ware JE, Aaronson NK, Apolone G, Bjorner JB, Brazier JE, et al.
Cross-validation of item selection and scoring for the SF-12 health survey in
nine countries: results from the IQOLA project. J Clin Epidemiol.
1998;51:1171–8.
38. Beecham JK, Knapp MRJ. Costing psychiatric interventions. In: Thornicroft G,
editor. Measuring mental health needs. London: Royal Collegues of
Psychiatrists; 2001. p. 200–24.
39. Vazquez-Barquero JL, Gaite L, Cuesta MJ, Garcia-Usieto E, Knapp M, Beecham
J. Spanish version of the CSRI: a mental health cost evaluation interview.
Arch Neurobiol. 1997;60:171–84.
40. Badia X. EuroQoL: un instrumento para valorar la salud EQ-5D guía del
usuario, versión española. Med Clin. 1999;114:6–14.
41. Badia X, Roset M, Herdman M, Kind P. A comparison of United Kingdom
and Spanish general population time trade-off values for EQ-5D health
states. Med Decis Making. 2001;21(1):7–16.
42. Watson D, Clark LA, Tellegen A. Development and validation of brief
measures of positive and negative affect: the PANAS scales. J Pers Soc
Psychol. 1988;54(6):1063–70.
43. Sandín B, Chorot P, Lostao L, Joiner TE, Santed MA, Valiente RM. Escalas
PANAS de afecto positivo y negativo: validacion factorial y convergencia
transcultural. Psicothema. 1999;11(1):37–51.
44. Baer RA, Smith GT, Hopkins J, Krietemeyer J, Toney L. Using self-report
assessment methods to explore facets of mindfulness. Assessment.
2006;13(1):27–45.
45. Cebolla A, García-Palacios A, Soler J, Guillen V, Baños R, Botella C.
Psychometric properties of the Spanish validation of the five facets of
mindfulness questionnaire (FFMQ). Eur J Psychiatry. 2012;26(2):118–26.
46. Hervás G, Vázquez C. Construction and validation of a measure of
integrative well-being in seven languages: the Pemberton happiness index.
Health Qual Life Outcomes. 2013;11(1):66.
47. López-Bastida J, Oliva J, Antoñanzas F, García-Altés A, Gisbert R, Mar J, et al.
Spanish recommendations on economic evaluation of health technologies.
Eur J Health Econ. 2010;11(5):513–20.
48. ISPOR: Good Outcomes Research Practices Index. http://www.ispor.org.
Accessed October 2014.
Castro et al. BMC Psychiatry  (2015) 15:106 Page 10 of 1049. Van Hout BA, Al MJ, Gordon GS, Rutten FF. Costs, effects and C/E-ratios
alongside a clinical trial. Health Econ. 2014;3(5):309–19.
50. Fenwick E, Claxton K, Sculpher M. Representing uncertainty: the role of cost-
effectiveness acceptability curves. Health Econ. 2001;10(8):779–87.
51. Fenwick E, Byford S. A guide to cost-effectiveness acceptability curves. Br J
Psychiatry. 2005;187:106–8.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
